CROs offering Protein Engineering with Biologics (Other)
8 published
8 published CROs match Protein Engineering and Biologics (Other).
Locations in this set include China, United Kingdom, United States, India, Netherlands, and South Korea.
Capabilities that show up most often in this set: Computational & In-Silico Drug Discovery, Discovery Research, Medicinal Chemistry, Target Identification & Validation, and Analytical Method Development & Validation.
Matching companies
- Accelagen, Inc.Accelagen is a Gene-to-Protein company providing protein expression, purification, and molecular biology services across baculovirus, mammalian, and E. coli systems.
Aragen Life SciencesGlobal CRDMO partner offering integrated discovery-to-commercialization services across small molecules and biologics, with 4000+ scientists and R&D/manufacturing campuses in Asia, North America, and Europe.
Aurigene Pharmaceutical Services LimitedIntegrated CRO-CDMO with 25+ years of discovery and development expertise across small and large molecules, operating 16 US FDA-inspected cGMP facilities across three manufacturing countries.
ChemPartnerGlobal preclinical CRO with 20+ years of experience supporting drug discovery through IND submission across small molecules and biologics, with 2,000+ scientists and facilities worldwide.
NuvisanFull-service CRO and CDMO with specialized competency centers in drug discovery, formulation development, GMP manufacturing, and bioanalytical services across Germany and France.
ProBioProBio is a leading global CDMO subsidiary of GenScript Biotech Corporation, providing end-to-end services for biologics and cell & gene therapy (CGT) from drug discovery through commercialization.
Sygnature DiscoverySygnature Discovery is an integrated drug discovery contract research organization offering target identification, hit-to-lead, lead optimization, computational design, protein science, and in vivo pharmacology services. The company partners with biotech and pharma clients across the US, Canada, the UK, and Europe.
WuXi AppTecGlobal CRDMO platform providing integrated end-to-end contract research, development, and manufacturing services across discovery, preclinical, clinical, and commercial phases for small molecules, peptides, oligonucleotides, and biologics across 30+ countries.
Markdown mirror: /explore/protein-engineering/biologics-other.md